Fang, Z.; Hu, Y.; Dai, J.; He, L.; He, J.; Xu, B.; Han, X.; Zhong, F.; Lan, H.; Wang, Q.
CS12192, a Novel JAK3/JAK1/TBK1 Inhibitor, Synergistically Enhances the Anti-Inflammation Effect of Methotrexate in a Rat Model of Rheumatoid Arthritis. Int. J. Mol. Sci. 2022, 23, 13394.
https://doi.org/10.3390/ijms232113394
AMA Style
Fang Z, Hu Y, Dai J, He L, He J, Xu B, Han X, Zhong F, Lan H, Wang Q.
CS12192, a Novel JAK3/JAK1/TBK1 Inhibitor, Synergistically Enhances the Anti-Inflammation Effect of Methotrexate in a Rat Model of Rheumatoid Arthritis. International Journal of Molecular Sciences. 2022; 23(21):13394.
https://doi.org/10.3390/ijms232113394
Chicago/Turabian Style
Fang, Zhengyu, Yiping Hu, Jiajing Dai, Lianhua He, Juan He, Bihua Xu, Xinle Han, Fubo Zhong, Huiyao Lan, and Qingwen Wang.
2022. "CS12192, a Novel JAK3/JAK1/TBK1 Inhibitor, Synergistically Enhances the Anti-Inflammation Effect of Methotrexate in a Rat Model of Rheumatoid Arthritis" International Journal of Molecular Sciences 23, no. 21: 13394.
https://doi.org/10.3390/ijms232113394
APA Style
Fang, Z., Hu, Y., Dai, J., He, L., He, J., Xu, B., Han, X., Zhong, F., Lan, H., & Wang, Q.
(2022). CS12192, a Novel JAK3/JAK1/TBK1 Inhibitor, Synergistically Enhances the Anti-Inflammation Effect of Methotrexate in a Rat Model of Rheumatoid Arthritis. International Journal of Molecular Sciences, 23(21), 13394.
https://doi.org/10.3390/ijms232113394